Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Total Non-Current Liabilities (2022 - 2023)

Historic Total Non-Current Liabilities for Therapeutics (LENZ) over the last 2 years, with Q3 2023 value amounting to $62.2 million.

  • Therapeutics' Total Non-Current Liabilities rose 28941.47% to $62.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $62.2 million, marking a year-over-year increase of 28941.47%. This contributed to the annual value of $14.8 million for FY2022, which is N/A changed from last year.
  • As of Q3 2023, Therapeutics' Total Non-Current Liabilities stood at $62.2 million, which was up 28941.47% from $62.9 million recorded in Q2 2023.
  • Over the past 5 years, Therapeutics' Total Non-Current Liabilities peaked at $62.9 million during Q2 2023, and registered a low of $14.8 million during Q4 2022.